Cite

    Orcun Altunoren et al.. “Can vasohibin‐1, an endothelium‐derived angiogenesis inhibitor, be a marker of endothelial dysfunction in hemodialysis patients?.” Seminars in dialysis, vol. 33, no. 5, 2020, pp. 418–427. http://access.bl.uk/ark:/81055/vdc_100107628152.0x000044